CD8A and neoplasm: Simultaneously, HDACi can upregulate relevant genes to enhance the ability of TAP1 and TAP2 to transport antigenic peptides to the ER for binding with MHC class I molecules, enabling more efficient transport and binding of antigenic peptides generated from tumor antigens expressed by INT, improving antigen presentation efficiency, and increasing opportunities for CD8+ T cell recognition [44,54].